Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein 90 alpha family class B member 2, pseudogene (HSP90AB2P) is a pseudogene and does not code for a functional protein in humans[1][5][6]. While it is homologous to the heat shock protein 90 (HSP90) family—molecular chaperones critical for protein folding, cellular stress response, and cancer biology—HSP90AB2P itself does not share these chaperone functions because it is non-coding. As with some other pseudogenes, there is a possibility that its *RNA transcript* could play a regulatory role, such as modulating gene expression through small RNA pathways, but there is no evidence of direct involvement in disease, patient stratification, or as a therapeutic protein target[1][4][5]. Any references to HSP90 chaperone activity, protein stabilization, or anti-cancer drug interactions refer to other *functional* HSP90 proteins, not to HSP90AB2P[1][3][5].
Not applicable. No direct mechanism of action for drugs, as HSP90AB2P does not encode an active protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein 90 alpha family class B member 2, pseudogene (HSP90AB2P).